Bacteraemia with extended-spectrum β-lactamases-producing Escherichia coli in Hong Kong

International Journal of Antimicrobial Agents

Volumn 34, Issue 6, 2009, Pages 611-612

  You, Joyce H S ^a   Mok, Shirley S M ^a   Chang, Candis C M ^a   Lee, Nelson ^b   Ip, Margaret ^c  

^a Prince of Wales Hospital   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; EXTENDED SPECTRUM BETA LACTAMASE; IMMUNOSUPPRESSIVE AGENT;

AGED; BACTEREMIA; BACTERIAL STRAIN; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; DRUG TREATMENT FAILURE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HEALTH CARE COST; HONG KONG; HUMAN; INFECTION RISK; LETTER; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 70350620726     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.07.015     Document Type: Letter

References (6)

1. You J.H.S., Kei H.W., Lau W.C., Wong K.Y., Marasinghe T., Lee N., et al. Are β-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum β-lactamases-producing Escherichia coli?. J Hosp Infect 68 (2008) 181-183
2. Ho P.L., Tsang D.N.C., Que T.L., Ho M., and Yuen K.Y. Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong. APMIS 108 (2000) 237-240
3. Lee S.Y., Kotapati S., Kuti J.L., Nightingale C.H., and Nicolau D.P. Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 27 (2006) 1226-1232
4. Paterson D.L., Ko W.C., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens H., et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 140 (2004) 26-32
5. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., and Fishman N.O. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32 (2001) 1162-1171
6. Schwaber M.J., Navon-Venezia S., Kaye K.S., Ben-Ami R., Schwartz D., and Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 50 (2006) 1257-1262